Rx to Go LLC, the in-house specialty pharmacy for Florida Cancer Specialists & Research Institute LLC (FCS), announced on Tuesday that it has received re-accreditation through Accreditation Commission for Health Care (ACHC) for pharmacy services with distinction in oncology through November 2028.
In the accreditation process, healthcare organisations must demonstrate compliance with national standards. Accreditation by ACHC reflects an organisation's dedication and commitment to meeting standards that facilitate a higher level of performance and patient care, Rx to Go said.
Rx To Go also has accreditation by URAC for Specialty Pharmacy and is dually accredited by the National Association of Boards of Pharmacy (NABP) for specialty pharmacy. FCS is also NABP accredited for digital pharmacy practice.
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Hemogenyx Pharmaceuticals advances HG-CT-1 trial and opens paediatric recruitment
Rx to Go receives ACHC re-accreditation for pharmacy services
Shanton Pharma completes SAP-001 End-of-Phase 2 meeting with US FDA
Fibronostics completes Stone Clinical Laboratories acquisition
Syngene International to add GMP bioconjugation suite in Bengaluru
Eli Lilly's single-injection, once-monthly maintenance Omvoh regimen receives US FDA approval
4basebio synthetic DNA used in Phase I/II mRNA therapy trial